Arkolith/Insider Trading/PMVP/Form 4

Gallagher Carol Giltner

DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Nov 8, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 5, 2022Gift(G)39K—$039K
Nov 5, 2022Gift(G)39K—$039K
Nov 4, 2022Grant(A)39K—$039K

Transaction Codes

G
Gift
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-056102) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML